บลูโอ๊คปรับมูลค่าเงินกู้โลพาเร็กซ์ลดลงเกือบเป็นศูนย์

OBDC moved its Loparex loan exposure to non-accrual and slashed the loan value to near zero, a direct hit to its portfolio valuation.

Blue Owl Capital's private credit valuation practices face fresh concerns after the Loparex write-down at its BDC.

Moody's downgraded Loparex's Probability of Default Rating over missed interest payments, a credit-rating action tied to the loan write-down.